Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 01/28/2026 | Q4 | $122.4M | -- | -- | $1.04 | -- |
| 10/22/2025 | Q3 | $113.8M | $131.3M | $0.49 | $0.92 | -$0.43 |
| 07/23/2025 | Q2 | $109.2M | $151M | $0.93 | $0.87 | $0.06 |
| 04/23/2025 | Q1 | $105.4M | $145.6M | $0.88 | $0.78 | $0.10 |
| 01/29/2025 | Q4 | $101.1M | $109.2M | $0.09 | $0.74 | -$0.65 |
| 10/23/2024 | Q3 | $97.9M | $145.7M | $0.45 | $0.70 | -$0.25 |
| 07/25/2024 | Q2 | $93.8M | $143.6M | $0.70 | $0.60 | $0.10 |
| 04/24/2024 | Q1 | $95.9M | $139.5M | $0.61 | $0.63 | -$0.02 |
| 01/24/2024 | Q4 | $99.1M | $141.1M | $0.72 | $0.65 | $0.07 |
| 10/25/2023 | Q3 | -- | $138.9M | $0.73 | -- | -- |
| 07/26/2023 | Q2 | -- | $135.4M | $0.71 | -- | -- |
| 04/26/2023 | Q1 | -- | $130.7M | $0.37 | -- | -- |
| 01/24/2023 | Q4 | -- | $107.7M | $1.07 | -- | -- |
| 10/26/2022 | Q3 | -- | $105.2M | $1.06 | -- | -- |
| 07/27/2022 | Q2 | -- | $98M | $1.03 | -- | -- |
| 04/27/2022 | Q1 | -- | $98.4M | $0.95 | -- | -- |
| 01/26/2022 | Q4 | -- | $91.3M | $0.29 | -- | -- |
| 10/25/2021 | Q3 | -- | $77M | $0.97 | -- | -- |
| 07/27/2021 | Q2 | -- | $82.7M | $1.03 | -- | -- |
| 05/10/2021 | Q1 | -- | $78.6M | $0.99 | -- | -- |
| 01/27/2021 | Q4 | -- | $79.1M | $0.82 | -- | -- |
| 10/26/2020 | Q3 | -- | $80.2M | $0.81 | -- | -- |
| 07/23/2020 | Q2 | -- | $84M | $0.56 | -- | -- |
| 04/28/2020 | Q1 | -- | $79.6M | $0.62 | -- | -- |
| 01/22/2020 | Q4 | -- | $75.4M | $0.71 | -- | -- |
| 10/23/2019 | Q3 | -- | $78.1M | $0.84 | -- | -- |
| 07/24/2019 | Q2 | -- | $79.3M | $0.80 | -- | -- |
| 04/23/2019 | Q1 | -- | $79.5M | $0.75 | -- | -- |
| 01/23/2019 | Q4 | -- | $75.7M | $0.80 | -- | -- |
| 10/23/2018 | Q3 | -- | $73.7M | $0.74 | -- | -- |
| 07/24/2018 | Q2 | -- | $72.8M | $0.77 | -- | -- |
| 04/24/2018 | Q1 | -- | $71M | $0.70 | -- | -- |
| 01/29/2018 | Q4 | -- | $68M | $0.48 | -- | -- |
| 10/24/2017 | Q3 | -- | $57.6M | $0.53 | -- | -- |
| 07/25/2017 | Q2 | -- | $57.9M | $0.45 | -- | -- |
| 04/27/2017 | Q1 | -- | $46.3M | $0.34 | -- | -- |
| 01/26/2017 | Q4 | -- | $42.6M | $0.40 | -- | -- |
| 11/09/2016 | Q3 | -- | $41.8M | $0.23 | -- | -- |
| 08/09/2016 | Q2 | -- | $41.4M | $0.37 | -- | -- |
| 05/04/2016 | Q1 | -- | $39.6M | $0.33 | -- | -- |
| 02/04/2016 | Q4 | -- | $39.3M | $0.33 | -- | -- |
First Bancorp (North Carolina) reported $131.3M worth of top line sales in its most recent quarter.
First Bancorp (North Carolina) announced earnings per share of $0.49 which represents a miss of analyst forecast a $0.92 per share.
First Bancorp (North Carolina) reported -- that represents -- per share over the last quarter.
First Bancorp (North Carolina)'s earnings are forecast to grow from $1.84 per share to $2.67 per share next year representing an increase of 105.78%.
First Bancorp (North Carolina)'s next earnings date is January 28, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.